Treatment of thyroid cancer cell lines with 5-Aza-2ʹ-deoxycytidine (5-Aza-CdR), which inhibited DNA methylation, led to INPP4B upregulation [34]. This evidence concerns the gene INPP4B and thyroid cancer.